BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00022542 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

NIH

Sponsor class

Conditions

Recurrent Adult Soft Tissue Sarcoma
Stage III Adult Soft Tissue Sarcoma
Stage IV Adult Soft Tissue Sarcoma

Interventions

DRUG: ixabepilone

Sponsor

National Cancer Institute (NCI)